Results 21 to 30 of about 3,094,120 (388)

Differences between bipolar disorder types 1 and 2 support the DSM two-syndrome concept

International Journal of Bipolar Disorders, 2022
Objective To compare characteristics of bipolar disorder patients diagnosed as DSM-5 types I (BD-1) vs. II (BD-2). Methods We compared descriptive, psychopathological, and treatment characteristics in a sample of 1377 consenting, closely and repeatedly ...
Leonardo Tondo, Alessandro Miola, Marco Pinna, Martina Contu, Ross J. Baldessarini   +4 more
doaj   +1 more source

Comprehensive review of multidimensional biomarkers in the ShangHai At Risk for Psychosis (SHARP) program for early psychosis identification

PCN Reports, 2023
Psychosis is recognized as one of the largest contributors to nonfatal health loss, and early identification can largely improve routine clinical activity by predicting the psychotic course and guiding treatment.
TianHong Zhang, LiHua Xu, XiaoChen Tang, YanYan Wei, YeGang Hu, HuiRu Cui, YingYing Tang, ChunBo Li, JiJun Wang   +8 more
doaj   +1 more source

Associations of mismatch negativity with psychotic symptoms and functioning transdiagnostically across psychotic disorders.

Journal of Abnormal Psychology, 2020
Mismatch negativity (MMN) amplitude has been widely shown to be diminished in schizophrenia and, more recently, in other psychotic disorders. Although there is considerable evidence linking MMN reduction to cognitive and functional deficits in ...
Kayla R. Donaldson, K. Novak, D. Foti, Maya A. Marder, G. Perlman, R. Kotov, Aprajita Mohanty   +6 more
semanticscholar   +1 more source

Elevated pulse pressure and its associations with demographic and clinical parameters in a clinically representative sample of outpatients with psychotic disorders

BJPsych Open, 2022
Elevated pulse pressure is associated with metabolic and neurocognitive diseases. Preliminary small-scale studies among patients with psychotic disorders have indicated that these patients had an increased pulse pressure compared with controls.
Christopher Holmberg, Jarl Torgerson, Andreas Gremyr   +2 more
doaj   +1 more source

Sarcosine May Induce EGF Production or Inhibit the Decline in EGF Concentrations in Patients with Chronic Schizophrenia (Results of the PULSAR Study)

Pharmaceuticals, 2023
Sarcosine (N-methylglycine), a glutamatergic modulator, reduces the primary negative symptoms of schizophrenia. These beneficial changes might be mediated by trophic factors such as epidermal growth factor (EGF).
Agnieszka Pawlak, Bartosz Kaczmarek, Adam Wysokiński, Dominik Strzelecki   +3 more
doaj   +1 more source

The bi-directional associations between psychotic experiences and DSM-IV mental disorders [PDF]

, 2017
OBJECTIVE: While it is now recognized that psychotic experiences are associated with an increased risk of later mental disorders, we lack a detailed understanding of the reciprocal time-lagged relationships between first onsets of psychotic experiences ...
Al-Hamzawi, Ali Obaid, Andrade, Laura Helena, Benjet, Corina, Bromet, Evelyn J., Browne, Mark Oakley, Caldas de Almeida, José Miguel, Chiu, Wai Tat, Demyttenaere, Koen, Fayyad, John, Florescu, Silvia E., Girolamo, Giovanni de, Gureje, Oye, Haro Abad, Josep Maria, Have, Margreet ten, Hu, Chiyi, Kendler, Kenneth S., Kessler, Ronald C., Kovess-Masfety, Viviane, Lim, Carmen C. W., McGrath, John J., Navarro Mateu, Fernando, Posada Villa, José, Saha, Sukanta, Sampson, Nancy A.   +23 more
core   +1 more source

20 years of daily hospital for non-psychotic disorders, organisational structure and treatment modalities

European Psychiatry, 2022
Introduction Anxiety and depressive disorders are among the most prevalent psychiatric disorders, yet there aren’t many studies adressing treatment modalities in daily hospitals.
S. Caratan, S. Kocijan Lovko, A. Ivrlač, L. Goršić, T. Matoš   +4 more
doaj   +1 more source

Psychotic Symptoms in Kenya - Prevalence, Risk Factors, and Relationship with Common Mental Disorders [PDF]

, 2012
There have been few epidemiological surveys to establish prevalence and associated risk factors of psychosis in Sub-Saharan Africa. This paper reports a population- based epidemiological survey in rural Kenya of the prevalence of psychotic symptoms and ...
Bebbington, David Kiima, Frank Njenga, James Ayuyo, Leucht, Lewis, Makheti Baraza, Marx Okonji, Ngoma, Nicola Singleton, Patel, Pius Kigamwa, Poulton, Rachel Jenkins, Sally McManus, van Os   +15 more
core   +3 more sources

Schizophrenia and Other Psychotic Disorders

Definitions, 2020
Address Laboratory for Clinical and Experimental Psychopathology, Harvard Commonwealth Research Center of Excellence in Clinical Neuroscience and Psychopharmacological Research, Fall River, MA, USA Department of Psychiatry, Beth Israel Deaconess Medical ...
David A. Wilder, Stephen E. Wong, Ansley C. Hodges, H. Ertel   +3 more
semanticscholar   +1 more source

TMS in Psychotic Disorders [PDF]

, 2020
Schizophrenia is one of the most disabling mental disorders with a large burden of disease. Treatment options for positive, negative and cognitive symptoms of schizophrenia are limited, and a third of the patients with schizophrenia respond insufficiently to antipsychotic medications.
André Aleman, Jozarni J. Dlabac-de Lange   +1 more
openaire   +2 more sources